Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis
- PMID: 28445663
- DOI: 10.1056/NEJMc1702076
Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis
Comment on
-
Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.N Engl J Med. 2017 Apr 27;376(17):1692. doi: 10.1056/NEJMc1702076. N Engl J Med. 2017. PMID: 28447769 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources